EX-LAX
- Product NDC
- 0067-8140
- 11-digit product format
- 000678140
- Labeler code
- 0067
- Product ID
- 0067-8140_0add1e20-57d2-4642-81ab-a356989ea677
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- SENNOSIDES
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Labeler
- Haleon US Holdings LLC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2017-08-01
- Substance
- SENNOSIDES
- Active strength
- 15 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Dataset | Scope | Package NDC |
|---|---|---|
| excluded product | product | |
| excluded package | package | 0067-8140-01 |
| excluded package | package | 0067-8140-02 |
| excluded package | package | 0067-8140-03 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EX-LAX
- Brand name suffix
- REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 15 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 59a26a7f-516f-4507-8dec-f40cf6cfaffc | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 0067-8140-01 | 2020-11-18 | Drug Facts |
| 0067-8140-02 | 2020-11-18 | Drug Facts |
| 0067-8140-03 | 2020-11-18 | Drug Facts |
| 0067-8140-01 | 2020-01-31 | Drug Facts |
| 0067-8140-02 | 2020-01-31 | Drug Facts |
| 0067-8140-03 | 2020-01-31 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0067-8140-01 | EX-LAXREGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | 12 in 1 PACKAGE | TABLET, CHEWABLE | 12 | 6 | |
| 0067-8140-01 | EX-LAXREGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | 1 in 1 BOX | TABLET, CHEWABLE | 1 | 6 | |
| 0067-8140-02 | EX-LAXREGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | 2 in 1 BOX | TABLET, CHEWABLE | 2 | 6 | |
| 0067-8140-02 | EX-LAXREGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | 12 in 1 PACKAGE | TABLET, CHEWABLE | 12 | 6 | |
| 0067-8140-03 | EX-LAXREGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | 12 in 1 PACKAGE | TABLET, CHEWABLE | 12 | 6 | |
| 0067-8140-03 | EX-LAXREGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE | 4 in 1 BOX | TABLET, CHEWABLE | 4 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0067-8140-01 | EA - Each | 0067-8140 | ef645ac1-a019-404b-9c71-1bf42c107024 | 1 | 2025-05-14 |
| 0067-8140-02 | EA - Each | 0067-8140 | dbe00176-bc5b-4c64-8e5a-7e5959799d5c | 1 | 2020-04-20 |
| 0067-8140-03 | EA - Each | 0067-8140 | 7695f527-3920-488e-97a5-76861ba357bf | 1 | 2024-11-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Publix Fiber Therapy Sugar Free | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | ed3dc80a-a243-4013-9886-b148e3e3b662 | 2025-10-28 | Warnings | M007 |
| Childrens Oral Saline Laxative | MAGNESIUM HYDROXIDE | WAL-MART STORES,INC., | a2eb50ab-851a-4abb-a12f-6d9d8b0cb6bc | 2025-10-27 | Warnings | M007 |
| equate Fiber Therapy | METHYLCELLULOSE | Wal-Mart Stores,Inc., | 7acc30b4-e946-42cd-8eec-cf15159d478d | 2025-10-27 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | CVS Pharmacy | c56e010a-7503-3e1c-e053-2a95a90a2b85 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Major Pharmaceuticals | c194c40c-c732-2f03-e053-2a95a90a7a40 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Pharmacy Value Alliance LLC | 8a6d6729-f6eb-4f68-e053-2a95a90a5c9e | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Cardinal Health | c2b33e78-6ab7-1785-e053-2995a90a9c4f | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 213071 | Ex-Lax Regular Strength Chocolated 15 MG Chewable Tablet | PSN | 59a26a7f-516f-4507-8dec-f40cf6cfaffc | 6 |
| 251020 | sennosides 15 MG Chewable Tablet | PSN | 59a26a7f-516f-4507-8dec-f40cf6cfaffc | 6 |
| 213071 | sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated] | SBD | 59a26a7f-516f-4507-8dec-f40cf6cfaffc | 6 |
| 251020 | sennosides, USP 15 MG Chewable Tablet | SCD | 59a26a7f-516f-4507-8dec-f40cf6cfaffc | 6 |
| 213071 | Ex-Lax Chocolated 15 MG Chewable Tablet | SY | 59a26a7f-516f-4507-8dec-f40cf6cfaffc | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0067-8140-01 | 00067814001 | 1 PACKAGE in 1 BOX (0067-8140-01) / 12 TABLET, CHEWABLE in 1 PACKAGE | 1 package | 2017-08-01 | 0000-00-00 | No | No | Current |
| 0067-8140-02 | 00067814002 | 2 PACKAGE in 1 BOX (0067-8140-02) / 12 TABLET, CHEWABLE in 1 PACKAGE | 2 package | 2017-08-01 | 0000-00-00 | No | No | Current |
| 0067-8140-03 | 00067814003 | 4 PACKAGE in 1 BOX (0067-8140-03) / 12 TABLET, CHEWABLE in 1 PACKAGE | 4 package | 2017-08-01 | 0000-00-00 | No | No | Current |